SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-23-073769
Filing Date
2023-06-22
Accepted
2023-06-22 16:19:12
Documents
40

Document Format Files

Seq Description Document Type Size
1 S-1 tm2313083-6_s1.htm S-1 2882446
2 EXHIBIT 3.1 tm2313083d7_ex3-1.htm EX-3.1 732654
3 EXHIBIT 3.2 tm2313083d7_ex3-2.htm EX-3.2 18811
4 EXHIBIT 3.3 tm2313083d7_ex3-3.htm EX-3.3 108898
5 EXHIBIT 10.2 tm2313083d7_ex10-2.htm EX-10.2 63223
6 EXHIBIT 10.3 tm2313083d7_ex10-3.htm EX-10.3 40750
7 EXHIBIT 10.4 tm2313083d7_ex10-4.htm EX-10.4 71703
8 EXHIBIT 10.5 tm2313083d7_ex10-5.htm EX-10.5 154571
9 EXHIBIT 10.6 tm2313083d7_ex10-6.htm EX-10.6 26465
10 EXHIBIT 10.7 tm2313083d7_ex10-7.htm EX-10.7 212059
11 EXHIBIT 10.8 tm2313083d7_ex10-8.htm EX-10.8 13769
12 EXHIBIT 10.9 tm2313083d7_ex10-9.htm EX-10.9 221890
13 EXHIBIT 10.10 tm2313083d7_ex10-10.htm EX-10.10 261845
14 EXHIBIT 10.11 tm2313083d7_ex10-11.htm EX-10.11 164598
15 EXHIBIT 10.12 tm2313083d7_ex10-12.htm EX-10.12 85285
16 EXHIBIT 10.13 tm2313083d7_ex10-13.htm EX-10.13 18870
17 EXHIBIT 21.1 tm2313083d7_ex21-1.htm EX-21.1 2191
18 EXHIBIT 23.1 tm2313083d7_ex23-1.htm EX-23.1 2078
19 EX-FILING FEES tm2313083d7_ex-filingfees.htm EX-FILING FEES 12987
20 GRAPHIC lg_apogeetherapeutics-4c.jpg GRAPHIC 131108
21 GRAPHIC tbl_apogeetarget-4c.jpg GRAPHIC 275577
22 GRAPHIC bc_indication-4c.jpg GRAPHIC 114257
23 GRAPHIC bc_nhphalf-4c.jpg GRAPHIC 75803
24 GRAPHIC pht_eczemaarea-4c.jpg GRAPHIC 390537
25 GRAPHIC tbl_morphological-4c.jpg GRAPHIC 286189
26 GRAPHIC bc_proportion-4c.jpg GRAPHIC 191157
27 GRAPHIC pht_apogee-4c.jpg GRAPHIC 704535
28 GRAPHIC lc_nhppkadministration-4c.jpg GRAPHIC 242738
29 GRAPHIC lc_humanhalf-4c.jpg GRAPHIC 88645
30 GRAPHIC lc_mrnaexpression-4c.jpg GRAPHIC 150678
31 GRAPHIC fc_disrupted-4c.jpg GRAPHIC 490358
32 GRAPHIC pht_human-4c.jpg GRAPHIC 446294
33 GRAPHIC lc_affinity-4c.jpg GRAPHIC 661798
34 GRAPHIC lc_normalized-4c.jpg GRAPHIC 156968
35 GRAPHIC lc_humanhalflife-4c.jpg GRAPHIC 162672
36 GRAPHIC bc_siggle-4c.jpg GRAPHIC 234927
37 GRAPHIC fc_signaling-4c.jpg GRAPHIC 483631
38 GRAPHIC lc_inhibition-4c.jpg GRAPHIC 157233
39 GRAPHIC fc_untreated-4c.jpg GRAPHIC 951569
40 GRAPHIC fc_antigen-4c.jpg GRAPHIC 831159
  Complete submission text file 0001104659-23-073769.txt   14468419
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-272831 | Film No.: 231033554
SIC: 2836 Biological Products, (No Diagnostic Substances)